Difference between revisions of "Team:San Andres"
| Line 6: | Line 6: | ||
</head> | </head> | ||
<body> | <body> | ||
| + | <meta content="text/html; charset=ISO-8859-1" | ||
| + | http-equiv="content-type"> | ||
| + | <title></title> | ||
<title>wiki</title> | <title>wiki</title> | ||
<meta http-equiv="Content-Type" | <meta http-equiv="Content-Type" | ||
| Line 308: | Line 311: | ||
<a href="https://igem.org/Team_List?year=2015"><img | <a href="https://igem.org/Team_List?year=2015"><img | ||
src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" | src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" | ||
| − | width="55"> | + | width="55"></a></td> |
| − | + | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
| Line 315: | Line 317: | ||
<div class="gwd-div-2ed9"></div> | <div class="gwd-div-2ed9"></div> | ||
<div class="gwd-div-7xzo gwd-a-1thu"> | <div class="gwd-div-7xzo gwd-a-1thu"> | ||
| − | <h1><big>Home</big> | + | <h1><big>Home</big></h1> |
| − | </h1> | + | <big>The celiac disease affects 1 in 265 people worldwide and 15% |
| − | + | of population in Chile. This in an irreversible autoimmune disease in | |
| − | + | which due to the presence of genes HLA DQ2 or HLA DQ8 in those | |
| − | celiac disease affects 1 in 265 people worldwide | + | affected, the consumption of foods containing gluten (all fods derived |
| − | and 15% of population in Chile. This | + | from wheat, barley, rye, etc.) cause an inflammation in small intestine |
| − | disease in | + | causing multiple effects in the organism (diarrhea, constipation, porr |
| − | which due to the presence of genes HLA DQ2 or HLA | + | absorption, among others) significantly affecting their quatily of life.</big><br> |
| − | affected, the | + | <big><br> |
| − | consumption of foods containing gluten (all | + | Whereas the majority of the world food contains gluten, we propose a |
| − | barley, | + | treatment for those who can't eat gluten, and can do so without |
| − | rye, etc.) cause an inflammation in | + | problems. In detail, our project involves a system able to degrade |
| − | multiple | + | |
| − | effects in the organism (diarrhea, constipation, | + | |
| − | others) | + | |
| − | significantly affecting their | + | |
| − | + | ||
| − | + | ||
| − | the majority of the world food contains | + | |
| − | gluten, we propose a treatment for those who | + | |
| − | do so | + | |
| − | + | ||
| − | degrade | + | |
gluten via the enzyme KumaMax and report the operation simultaneously | gluten via the enzyme KumaMax and report the operation simultaneously | ||
| − | with a | + | with a red fluorescent protein. The foregoing, works in a genetically |
| − | red fluorescent protein. The foregoing, works in a genetically modified | + | modified E. coli bacteria. With this project, in long run, we hope to |
| − | E. coli | + | improve the quality of life of all those reported with celiac disease</big>. |
| − | bacteria. With this project, in | + | <big>We belong to the San Andres School, representing Chile.</big><span |
| − | quality of | + | style="font-size: 11.5pt; font-family: "Arial","sans-serif"; color: black;" |
| − | life of all those reported with celiac disease | + | lang="EN-US"><big><br> |
| − | + | </big></span></div> | |
| − | style="font-size: | + | |
| − | lang="EN-US"><big>< | + | |
| − | </div> | + | |
<div style="text-align: left;"><br> | <div style="text-align: left;"><br> | ||
| | ||
| Line 359: | Line 347: | ||
</div> | </div> | ||
<div class="gwd-div-a9c8"></div> | <div class="gwd-div-a9c8"></div> | ||
| + | <br> | ||
<br> | <br> | ||
<br> | <br> | ||
Revision as of 14:21, 15 July 2015
| Home | Team | Project | Statistics | Enzymes | Parts | Metodology | Results | Future Projections |
 |
Home
The celiac disease affects 1 in 265 people worldwide and 15% of population in Chile. This in an irreversible autoimmune disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those affected, the consumption of foods containing gluten (all fods derived from wheat, barley, rye, etc.) cause an inflammation in small intestine causing multiple effects in the organism (diarrhea, constipation, porr absorption, among others) significantly affecting their quatily of life.Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. We belong to the San Andres School, representing Chile.
